World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
22571
World Ranking
2478
National Ranking
1186

Lynda C. Schneider publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lynda C. Schneider sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 253 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lynda C. Schneider D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lynda C. Schneider sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lynda C. Schneider is affiliated with Boston Children's Hospital in the United States and has a focused research profile in the field of Medicine, with significant contributions to Immunology and Allergy, Dermatology, and Physiology. Their work spans several subfields, particularly Immunology and Allergy, Dermatology, Physiology, Immunology, and Biotechnology.

The main topics covered by Schneider's research include:

  • Dermatology and Skin Diseases
  • Food Allergy and Anaphylaxis Research
  • Allergic Rhinitis and Sensitization
  • Asthma and respiratory diseases
  • Contact Dermatitis and Allergies
  • Transgenic Plants and Applications
  • Urticaria and Related Conditions

They have co-authored numerous publications with frequent collaborators including Jennifer LeBovidge, Derek K. Chu, Jonathan M. Spergel, Peck Y. Ong, and Matthew Greenhawt.

Schneider's work is regularly published in key venues within allergy and immunology research. Frequent publication venues include:

  • Journal of Allergy and Clinical Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Annals of Allergy Asthma & Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Allergy

Recent papers feature research on pediatric and allergic conditions. Selected titles include:

  • "Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial" (2022, The Lancet)
  • "Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations" (2023, Annals of Allergy Asthma & Immunology)
  • "Severity grading system for acute allergic reactions: A multidisciplinary Delphi study" (2021, Journal of Allergy and Clinical Immunology)
  • "Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy" (2023, New England Journal of Medicine)
  • "Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials" (2023, Journal of Allergy and Clinical Immunology)

The diversity in publication venues, topics, and co-authorship networks reflects a broad engagement with ongoing issues in allergy, dermatology, and related immune disorders. The focus on clinical trials, guidelines, and systematic reviews indicates contributions to evidence-based practice and treatment advances, particularly in pediatric populations.

Best Publications

  • Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report

    Joshua A. Boyce;Amal Assa'ad;A. Wesley Burks;Stacie M. Jones

  • Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel

    Alkis Togias;Susan F. Cooper;Maria L. Acebal;Amal Assa'ad

  • Cytokine modulation of atopic dermatitis filaggrin skin expression

    Michael D. Howell;Byung Eui Kim;Peisong Gao;Audrey V. Grant

  • TACI is mutant in common variable immunodeficiency and IgA deficiency.

    Emanuela Castigli;Stephen A Wilson;Lilit Garibyan;Rima Rachid

  • Effect of Anti-IgE Therapy in Patients with Peanut Allergy

    Donald Y.M. Leung;Hugh A. Sampson;John W. Yunginger;A. Wesley Burks

  • Tight junction defects in patients with atopic dermatitis.

    Anna De Benedetto;Nicholas M. Rafaels;Laura Y. McGirt;Andrei I. Ivanov

  • A Novel X-Linked Disorder of Immune Deficiency and Hypohidrotic Ectodermal Dysplasia Is Allelic to Incontinentia Pigmenti and Due to Mutations in IKK-gamma (NEMO)

    Jonathan Zonana;Melissa E. Elder;Lynda C. Schneider;Seth J. Orlow

  • Atopic dermatitis: A practice parameter update 2012

    Lynda Schneider;Stephen Tilles;Peter Lio;Mark Boguniewicz

  • Rapid oral desensitization in combination with omalizumab therapy in patients with cow’s milk allergy

    Kari C. Nadeau;Lynda C. Schneider;Lisa Hoyte;Irene Borras

  • Cytokine modulation of atopic dermatitis filaggrin skin expression.

    Unknown

  • Recombinant interferon gamma therapy for atopic dermatitis.

    Jon M. Hanifin;Lynda C. Schneider;Donald Y.M. Leung;Charles N. Ellis

  • Omalizumab facilitates rapid oral desensitization for peanut allergy

    Andrew J. MacGinnitie;Rima Rachid;Hana Gragg;Sara V. Little

  • A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients

    Lynda C. Schneider;Rima Rachid;Jennifer LeBovidge;Emily Blood

  • Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

    Lisa A. Beck;Mark Boguniewicz;Tissa Hata;Lynda C. Schneider

  • Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum.

    Pei Song Gao;Nicholas M. Rafaels;Tracey Hand;Tanda Murray

  • Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations

    Jordan S. Orange;Scott R. Brodeur;Ashish Jain;Francisco A. Bonilla

  • Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion among Children with Peanut Allergy: The PEPITES Randomized Clinical Trial

    David M. Fleischer;Matthew Greenhawt;Gordon Sussman;Philippe Bégin

  • Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

    Unknown

  • The presentation and natural history of immunodeficiency caused by nuclear factor κB essential modulator mutation

    Jordan S Orange;Ashish Jain;Zuhair K Ballas;Lynda C Schneider

  • An Evaluation of an Innovative Multimedia Educational Software Program for Asthma Management: Report of a Randomized, Controlled Trial

    C Homer;O Susskind;H R Alpert;M s Owusu

  • DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation

    Haifa H. Jabara;Douglas R. McDonald;Erin Janssen;Michel J. Massaad

  • Assessment of psychological distress among children and adolescents with food allergy

    Jennifer S. LeBovidge;Heather Strauch;Leslie A. Kalish;Lynda C. Schneider

Frequent Co-Authors

Lisa A. Beck
Lisa A. Beck University of Rochester Medical Center
Jon M. Hanifin
Jon M. Hanifin Oregon Health & Science University
Wanda Phipatanakul
Wanda Phipatanakul Boston Children's Hospital
Kathleen C. Barnes
Kathleen C. Barnes University of Colorado Denver
Mark Boguniewicz
Mark Boguniewicz National Jewish Health
Raif S. Geha
Raif S. Geha Boston Children's Hospital
Donald Y.M. Leung
Donald Y.M. Leung National Jewish Health
Nicholas Rafaels
Nicholas Rafaels University of Colorado Denver
Hugh A. Sampson
Hugh A. Sampson Icahn School of Medicine at Mount Sinai
Amal Assa'ad
Amal Assa'ad Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare degrees offer diverse career pathways, particularly in nursing and advanced practice. Transitioning your focus can expand your expertise and job opportunities. For example, moving from a family nurse practitioner role to a more specialized setting is possible by following guidance on how to fnp to acute care np transitions.

Accelerated programs make it easier for registered nurses to advance quickly. Programs highlighted under accelerated rn to np programs offer flexible online learning tailored for working professionals aiming to become nurse practitioners.

For individuals starting without a nursing background, online options such as online rn programs for non nurses in florida provide a pathway to enter the nursing field. These programs are structured to accommodate those switching careers to healthcare from unrelated fields.

If accessing education quickly is a priority, exploring the easiest accelerated nursing programs to get into can help identify schools with simpler entry requirements, making the transition into nursing or related healthcare careers more attainable.

Best Scientists Citing Lynda C. Schneider

Trending Scientists

Recently Published Articles